LIPOCINE INC. Unrealized Gain (Loss) on Derivatives
LIPOCINE INC. (LPCN) reported Unrealized Gain (Loss) on Derivatives of $17.17 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2026-03-10
- LIPOCINE INC. unrealized gain (loss) on derivatives for the quarter ending 2024-12-31 was $3.59K, a 70.78% decline year-over-year.
- LIPOCINE INC. unrealized gain (loss) on derivatives for the quarter ending 2024-09-30 was $138.08K, a 84.53% increase year-over-year.
- LIPOCINE INC. unrealized gain (loss) on derivatives for the quarter ending 2024-06-30 was -$84.43K, a 407.52% decline year-over-year.
- LIPOCINE INC. unrealized gain (loss) on derivatives for the quarter ending 2024-03-31 was -$40.07K, a 140.83% decline year-over-year.
- LIPOCINE INC. unrealized gain (loss) on derivatives for fiscal 2024 was $17.17K, a 91.93% decline from fiscal 2023.
- LIPOCINE INC. unrealized gain (loss) on derivatives for fiscal 2023 was $212.69K, a 62.42% decline from fiscal 2022.
- LIPOCINE INC. unrealized gain (loss) on derivatives for fiscal 2022 was $565.94K, a 59.02% increase from fiscal 2021.
- LIPOCINE INC. unrealized gain (loss) on derivatives for fiscal 2021 was $355.89K.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2024-12-31 | $3.59K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $141.67K derived: sum of 2 quarters · filed 2026-03-10 | $57.24K derived: sum of 3 quarters · filed 2026-03-10 | $17.17K 10-K · filed 2026-03-10 |
| 2024-09-30 | $138.08K 10-Q · filed 2025-11-06 | $53.65K derived: sum of 2 quarters · filed 2025-11-06 | $13.58K 10-Q · filed 2025-11-06 | $25.85K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$84.43K 10-Q · filed 2025-08-05 | -$124.50K 10-Q · filed 2025-08-05 | -$112.23K derived: sum of 3 quarters · filed 2025-08-05 | -$37.40K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$40.07K 10-Q · filed 2025-05-08 | -$27.80K derived: sum of 2 quarters · filed 2025-05-08 | $47.03K derived: sum of 3 quarters · filed 2025-05-08 | $74.48K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $12.27K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $87.10K derived: sum of 2 quarters · filed 2025-03-13 | $114.56K derived: sum of 3 quarters · filed 2025-03-13 | $212.69K 10-K · filed 2025-03-13 |
| 2023-09-30 | $74.83K 10-Q · filed 2024-11-07 | $102.28K derived: sum of 2 quarters · filed 2024-11-07 | $200.42K 10-Q · filed 2024-11-07 | $234.66K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $27.45K 10-Q · filed 2024-08-08 | $125.59K 10-Q · filed 2024-08-08 | $159.83K derived: sum of 3 quarters · filed 2024-08-08 | $486.07K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $98.13K 10-Q · filed 2024-05-09 | $132.38K derived: sum of 2 quarters · filed 2024-05-09 | $458.62K derived: sum of 3 quarters · filed 2024-05-09 | $1.04M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $34.24K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $360.48K derived: sum of 2 quarters · filed 2024-03-07 | $943.93K derived: sum of 3 quarters · filed 2024-03-07 | $565.94K 10-K · filed 2024-03-07 |
| 2022-09-30 | $326.24K 10-Q · filed 2023-11-08 | $909.68K derived: sum of 2 quarters · filed 2023-11-08 | $531.70K 10-Q · filed 2023-11-08 | $381.38K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $583.45K 10-Q · filed 2023-08-10 | $205.46K 10-Q · filed 2023-08-10 | $55.14K derived: sum of 3 quarters · filed 2023-08-10 | $535.09K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$377.99K 10-Q · filed 2023-05-11 | -$528.31K derived: sum of 2 quarters · filed 2023-05-11 | -$48.35K derived: sum of 3 quarters · filed 2023-05-11 | $172.97K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$150.32K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $329.63K derived: sum of 2 quarters · filed 2023-03-10 | $550.96K derived: sum of 3 quarters · filed 2023-03-10 | $355.89K 10-K · filed 2023-03-10 |
| 2021-09-30 | $479.95K 10-Q · filed 2022-11-09 | $701.27K derived: sum of 2 quarters · filed 2022-11-09 | $506.21K 10-Q · filed 2022-11-09 | $640.02K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $221.32K 10-Q · filed 2022-08-08 | $26.26K 10-Q · filed 2022-08-08 | $160.06K derived: sum of 3 quarters · filed 2022-08-08 | $300.54K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$195.06K 10-Q · filed 2022-05-09 | -$61.26K derived: sum of 2 quarters · filed 2022-05-09 | $79.22K derived: sum of 3 quarters · filed 2022-05-09 | -$1.99M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $133.81K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $274.29K derived: sum of 2 quarters · filed 2022-03-09 | -$1.79M derived: sum of 3 quarters · filed 2022-03-09 | -$2.89M 10-K · filed 2022-03-09 |
| 2020-09-30 | $140.48K 10-Q · filed 2021-11-10 | -$1.93M derived: sum of 2 quarters · filed 2021-11-10 | -$3.03M 10-Q · filed 2021-11-10 | -$2.79M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$2.07M 10-Q · filed 2021-08-05 | -$3.17M 10-Q · filed 2021-08-05 | -$2.93M derived: sum of 3 quarters · filed 2021-08-05 | -$2.93M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$1.10M 10-Q · filed 2021-05-06 | -$863.63K derived: sum of 2 quarters · filed 2021-05-06 | -$863.63K derived: sum of 3 quarters · filed 2021-05-06 | -$863.63K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $236.40K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $236.40K derived: sum of 2 quarters · filed 2021-03-11 | $236.40K derived: sum of 3 quarters · filed 2021-03-11 | $236.40K 10-K · filed 2021-03-11 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $0.00 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | ||
| 2018-12-31 | $0.00 10-K · filed 2020-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |